Twist Bioscience Corporation (FRA:0ME)

Twist Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-77.67	-208.73	-204.62	-217.86	-152.1
Depreciation & Amortization	21.95	28.83	29.31	16.51	9.75
Other Amortization	2.9	2.6	-	-	-
Loss (Gain) From Sale of Assets	-48.85	-	-	-4.61	-
Asset Writedown & Restructuring Costs	-	44.93	6.79	-	-
Stock-Based Compensation	64.46	50.93	30.28	79.66	37
Other Operating Activities	2.18	1.93	-3.22	7.26	2.49
Change in Accounts Receivable	-22.38	8.44	-4.32	-9.62	-2.2
Change in Inventory	-4.23	7.99	7.24	-7.54	-19.49
Change in Accounts Payable	9.33	-11.81	-2.51	7.38	8.54
Change in Other Net Operating Assets	4.67	10.79	-1.42	4.42	3.77
Operating Cash Flow	-47.63	-64.09	-142.47	-124.39	-112.24
Capital Expenditures	-28	-5.08	-27.78	-101.86	-27.06
Cash Acquisitions	-	-	-	-8.16	-0.48
Divestitures	2.5	-	-	-5.76	-
Investment in Securities	0.74	2.01	78.39	-117.16	183.7
Investing Cash Flow	-24.76	-3.07	50.61	-232.93	156.16
Long-Term Debt Repaid	-	-	-	-1.56	-3.33
Net Debt Issued (Repaid)	-	-	-	-1.56	-3.33
Issuance of Common Stock	13.56	10.87	5.32	279.85	343.36
Repurchase of Common Stock	-0.02	-3.98	-4.41	-7.75	-10.85
Other Financing Activities	15	-	-	-	-
Financing Cash Flow	28.54	6.89	0.91	270.53	329.18
Foreign Exchange Rate Adjustments	0.14	0.13	-0.03	-0.32	0.02
Net Cash Flow	-43.71	-60.15	-90.98	-87.1	373.11
Free Cash Flow	-75.63	-69.17	-170.25	-226.24	-139.31
Free Cash Flow Margin	-20.08%	-22.10%	-69.46%	-111.14%	-105.27%
Free Cash Flow Per Share	-1.26	-1.19	-2.99	-4.20	-2.89
Cash Interest Paid	-	-	-	0.01	0.17
Cash Income Tax Paid	0.68	0.34	0.42	0.25	0.1
Levered Free Cash Flow	-32.63	-17.42	-112.43	-160.52	-73.09
Unlevered Free Cash Flow	-32.63	-17.42	-112.43	-160.47	-72.86
Change in Working Capital	-12.61	15.41	-1.01	-5.36	-9.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.